CA2494916A1 - Composition medicale abaissant le taux de lipides sanguins - Google Patents

Composition medicale abaissant le taux de lipides sanguins Download PDF

Info

Publication number
CA2494916A1
CA2494916A1 CA002494916A CA2494916A CA2494916A1 CA 2494916 A1 CA2494916 A1 CA 2494916A1 CA 002494916 A CA002494916 A CA 002494916A CA 2494916 A CA2494916 A CA 2494916A CA 2494916 A1 CA2494916 A1 CA 2494916A1
Authority
CA
Canada
Prior art keywords
medicinal composition
hmg
coa reductase
bile
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002494916A
Other languages
English (en)
Inventor
Tatsuhito Kondo
Ikuo Takagi
Masato Nakayama
Yasuhiro Torizumi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2494916A1 publication Critical patent/CA2494916A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne une composition médicale abaissant le taux de lipides sanguins contenant un inhibiteur de d'HMG-CoA réductase et des acides biliaires.
CA002494916A 2002-08-08 2003-08-06 Composition medicale abaissant le taux de lipides sanguins Abandoned CA2494916A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002231618 2002-08-08
JP2002/231618 2002-08-08
PCT/JP2003/010028 WO2004014427A1 (fr) 2002-08-08 2003-08-06 Composition medicale abaissant le taux de lipides sanguins

Publications (1)

Publication Number Publication Date
CA2494916A1 true CA2494916A1 (fr) 2004-02-19

Family

ID=31711752

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002494916A Abandoned CA2494916A1 (fr) 2002-08-08 2003-08-06 Composition medicale abaissant le taux de lipides sanguins

Country Status (5)

Country Link
CN (1) CN1688341A (fr)
AU (1) AU2003257814A1 (fr)
CA (1) CA2494916A1 (fr)
TW (1) TW200404533A (fr)
WO (1) WO2004014427A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019018155A1 (fr) * 2017-07-17 2019-01-24 Eli Lilly And Company Compositions pharmaceutiques
CN109248152B (zh) * 2018-11-02 2021-01-12 河北医科大学第二医院 一种治疗肝胆疾病的药物制剂及其制备方法
CN113563404B (zh) * 2020-04-28 2024-03-12 华东师范大学 胆酸衍生物的制备方法

Also Published As

Publication number Publication date
AU2003257814A1 (en) 2004-02-25
WO2004014427A1 (fr) 2004-02-19
CN1688341A (zh) 2005-10-26
TW200404533A (en) 2004-04-01

Similar Documents

Publication Publication Date Title
US20050187204A1 (en) Medicinal composition for lowering blood lipid level
EP1715865B9 (fr) Agent therapeutique contre l hyperlipémie contenant des pitavastatines et l'acide eicosapentaénoïque
US20090042911A1 (en) Drug combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-YL](3R,5S)-3, 5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of P450 isoenzyme 3A4
US20150272944A1 (en) Novel triglyceride reducing agent
JP2010077162A (ja) 血中ホモシステイン低下のための医薬組成物
KR20020086749A (ko) 베타 블록커 및 콜레스테롤 저하제의 신규한 조합물
US20050182036A1 (en) Medicinal composition containing an HMG-CoA reductase inhibitor
CA2494916A1 (fr) Composition medicale abaissant le taux de lipides sanguins
JP4454985B2 (ja) 血液脂質を低下させるための医薬組成物
JP2002518448A (ja) 高血中コレステロールを治療する組成物および方法
US20080070938A1 (en) Medicinal composition for mitigating blood lipid or lowering blood homocysteine
JP4607436B2 (ja) ＨＭＧ−ＣｏＡリダクターゼ阻害剤を含有する医薬組成物
RU2246302C2 (ru) Фармацевтическая композиция для профилактики и лечения нарушений липидного обмена
CA2494801A1 (fr) Composition medicamenteuse contenant un inhibiteur de hmg-coa reductase
JP2002145774A (ja) 医薬組成物
JP4611622B2 (ja) 血中脂質改善又は血中ホモシステイン低下のための医薬組成物
CA2657394A1 (fr) Preparation contenant un agent du type fibrate et methode de production connexe
CN100415235C (zh) 含有HMG-CoA还原酶抑制剂的药物组合物
EP1358879A1 (fr) Agents hypolipemiants
JP2007008923A (ja) フィブラート系薬剤を含有する製剤及びその製造方法

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead